We just returned from a trip to India to attend the SCRAC (Society of Cancer Research and Communication) meeting in the coastal town of Juhu, Mumbai, India. We had the opportunity to meet radiation oncologists and cancer specialists from the region, and to present our pitch for hyperthermia. We have received positive indications that there will be several Pyrexar Medical Hyperthermia suites installed in India in 2019.
-
SCARC Conference, Mumbai, India
Pyrexar invited to present at the Society for Cancer Research and Communication (SCARC) meeting in Mumbai -
SCRAC Event
Dr. Mitusha Verma of Nanavati Hospital presents an Introduction to MRI Imaging. -
Dr. Nagraj G. Huilgol
Also speaking, long time hyperthermia luminary, Dr. Nagraj G. Huilgol, currently the Chief Radiation Oncologist at Nanavati hospital. Dr. Huilgol spoke on use of MRI to study heat-induced changes for diagnostics and MRTI. -
Nanavati Team at SCRAC
(left to right) Mr. Ketan Desai (CEO, Kirloskar Technologies); Ms. Neela Pai Dhungad( Clinical Research Coordinator, Incharge of Rehab Counseling & Manager-ACRO); Dr. Nagraji Huilgol (Chief Radiation Oncologist, Nanavati Hospital); Mark Falkowski (CEO, Pyrexar Medical) -
Nanavati Super Specialty Hospital
Dr. Rajendra Patankar, COO & Dr. Deepak Patkar (Director, Medical Services & Head of Department of Imaging ) of Nanavati Super Specialty Hospital, Parle West, Mumbai -
We had the opportunity to visit Tata Memorial Hospital in Parel, Mumbai. Considered a Top 10 hospital in India.
-
Visit to Tata Memorial Hospital in Parel
Dr. Suyesh S Kulkarni(Prof & Head, Department of Radiodiagnosos) & colleagues at Tata Memorial Hospital, Parel, Mumbai -
Dept. of Radiation Oncology
Pyrexar envoy with Dr. J P Agarwal - Prof & Head, Department of Radiation Oncology at Tata Memorial Hospital -
New Cancer Center Opening
Dr. Jigna Bhattacharya and the opening of her new clinic at Gandhinagar, Gujarat, India -
Cancer Care Team
Radiation Oncologists - Dr. Ashish Kumar, and Dr. Jigna Bhattacharya at the Cancer Care clinic with the Pyrexar Sales Team.
India is projected to be the world's most populous country by 2024. Surpassing the population of China, it is expected to be home to more than 1.7 billion people by 2050. With this continuing growth, the demand for health services also grows. The opportunities in the country are vast, and it appears hyperthermia has a chance to gain a foothold as a valuable adjunct cancer treatment.
SCRAC 2019 Program
Introduction to MRI Imaging - Dr. Mitusha Verma; Nanavati Hospital
Texture analysis - a novel technique in Radio-genomics - Dr. Balaji Ganeshan; Chief Executive Officer TexRAD Ltd UK
Introduction to MRI with Hyperthermia - Mr. Mark Falkowski, CEO; Pyrexar Medical
MRI to study heat induced changes for diagnostics and MRTI - Dr. Nagraj Huilgol; Nanavati Hospital
Group discussion to explore the possibilities to harness heat for diagnostics.